Morrow, OH, United States of America

Matthew John Laufersweiler


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Cincinnati, OH (US) (2004)
  • Morron, OH (US) (2005)
  • Morrow, OH (US) (2003 - 2008)

Company Filing History:


Years Active: 2003-2008

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Matthew John Laufersweiler

Introduction

Matthew John Laufersweiler is a notable inventor based in Morrow, Ohio, with a significant contribution to the field of pharmaceuticals. He holds a total of eight patents, showcasing his innovative approach to controlling inflammatory responses in humans. His work has implications for various disease states, making him a key figure in medical research and development.

Latest Patents

Among his latest patents, Laufersweiler has developed 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones that control inflammatory cytokines. This invention relates to a compound that includes all enantiomeric and diasteriomeric forms and pharmaceutically acceptable salts. The compound is designed to control, mediate, or abate disease states affected by extracellular inflammatory cytokines such as interleukin-1 (IL-1), Tumor Necrosis Factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-8 (IL-8). Another significant patent involves 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones that provide analgesia. This invention focuses on compounds capable of preventing the extracellular release of inflammatory cytokines, which can be crucial in managing pain and inflammation.

Career Highlights

Laufersweiler is currently associated with The Procter & Gamble Company, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong emphasis on addressing inflammation-related health issues, which are prevalent in various medical conditions.

Collaborations

Throughout his career, Laufersweiler has collaborated with notable colleagues, including Michael Philip Clark and Biswanath De. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Matthew John Laufersweiler's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving health outcomes. His work in controlling inflammatory cytokines is particularly significant in the ongoing battle against various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…